94. Primary sclerosing cholangitis Clinical trials / Disease details
Clinical trials : 148 / Drugs : 118 - (DrugBank : 39) / Drug target genes : 18 - Drug target pathways : 141
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04006886 (ClinicalTrials.gov) | July 11, 2017 | 2/7/2019 | Gluten-free Diet in Patients With Primary Sclerosing Cholangitis (PSC) | Gluten-free Diet in Patients With Primary Sclerosing Cholangitis (PSC) - a Pilot-Study | Reduction of Intestinal Inflammatory Activity | Dietary Supplement: Gluten-free diet | Universitätsklinikum Hamburg-Eppendorf | Institute for Clinical Molecular Biology, Christian-Albrechts-University, Kiel;Johannes Gutenberg University Mainz | Completed | 18 Years | 65 Years | All | 17 | N/A | Germany |